|
| Press Releases |
|
 |
|
| Monday, December 15, 2025 |
|
|
CMS (867.HK/8A8.SG): Innovative Drug Oral JAK1 Inhibitor Povorcitinib Has Been Included in the List of Breakthrough Therapeutic Drugs in China |
| more info >> |
|
| Thursday, December 11, 2025 |
|
|
CMS (867/8A8): NDA of Innovative Drug Y-3 for Injection for Acute Ischemic Stroke Accepted in China |
| China Medical System Holdings Limited (the "Group" or "CMS") is pleased to announce that on 11 December 2025, the New Drug Application (NDA) of Class 1 Innovative Drug Y-3 for Injection (proposed English generic name: Loberamisal for Injection) ("Y-3 for Injection" or the "Product") has been accepted by National Medical Products Administration of the People's Republic of China (NMPA). The Product is a brain cytoprotectant indicated for the treatment of acute ischemic stroke. more info >> |
|
| Thursday, October 30, 2025 |
|
|
CMS (867.HK; 8A8.SG) NDA for AD Indication of Long-acting Anti-IL-4Ra Humanized Monoclonal Antibody Injection MG-K10 Accepted in China |
| China Medical System Holdings Limited ("CMS") is pleased to announce that its subsidiary, Dermavon Holdings Limited ("Dermavon", an innovative pharmaceutical company specialized in skin health which is applying for a separate listing on the Main Board of The Stock Exchange of Hong Kong Limited, please refer to the announcement of CMS on 22 April 2025 for details) together with its subsidiaries, holds co-development rights (except for atopic dermatitis (AD)) and exclusive commercialization rights for the Class 1 innovative drug anti-IL-4Rα MG-K10 humanized monoclonal antibody injection ("MG-K10" or the "Product"). more info >> |
|
| Monday, October 27, 2025 |
|
|
CMS (867.HK; 8A8.SG) Signed A Distribution Agreement for Ophthalmic Drugs Lucentis(R) and Beovu(R) |
| more info >> |
|
| Sunday, September 28, 2025 |
|
|
China Medical System (867.HK; 8A8.SG) Positive Results from China Phase 3 Clinical Trial of Innovative Drug Ruxolitinib Cream with AD Indication |
| China Medical System Holdings Limited ("CMS") is pleased to announce that its subsidiaries, Dermavon Holdings Limited ("Dermavon", an innovative pharmaceutical company specialized in skin health which is applying for a separate listing on the Main Board of The Stock Exchange of Hong Kong Limited, please refer to the announcement published by CMS on 22 April 2025 for details) together with its subsidiaries, obtained positive results from the phase 3 clinical trial (the "Trial") of ruxolitinib cream (the "Product") in patients with mild to moderate atopic dermatitis (AD) in China. more info >> |
|
| Tuesday, September 23, 2025 |
|
|
China Medical System (867.HK; 8A8.SG) Signed Collaboration Agreements for Two Innovative Biologics Used for Passive Immunization Against Tetanus and Rabies |
| China Medical System Holdings Limited ("CMS" or the "Group") is pleased to announce that on 22 September 2025, the Group through its subsidiaries entered into two separate exclusive Collaboration Agreements (the "Agreements") with Chongqing Genrix Biopharmaceutical Co., Ltd. ("Genrix Bio") for two Class 1 therapeutic biological products, Vecantoxatug Injection (GR2001, "Vecantoxatug") indicated for passive immunization against tetanus and Silevimig Injection (GR1801, "Silevimig") indicated for passive immunization following suspected rabies virus exposure, respectively. more info >> |
|
| Tuesday, August 19, 2025 |
|
|
CMS (867.HK, 8A8.SG) Reports Growth in Revenue and Profit for H1 2025, Strategic Transformation Unlocks New Drivers |
| On 18 August, China Medical System Holdings Limited ("CMS" or the "Company") announced its interim results for the six months ended 30 June 2025 (the "Reporting Period"), with both revenue and profit recording year-on-year growth, demonstrating the initial results of its strategic transformation. more info >> |
|
| Tuesday, July 29, 2025 |
|
|
China Medical System (867.HK, 8A8.SG) NDA for the Improved New Drug ZUNVEYL for Alzheimer's Disease Accepted in China |
| China Medical System Holdings Limited ("CMS" or the "Group") is pleased to announce that on 28 July 2025, the New Drug Application (NDA) for improved new drug ZUNVEYL (Benzgalantamine Gluconate Enteric-coated Tablets) ("ZUNVEYL" or the "Product") has been accepted by the National Medical Products Administration of China (NMPA). more info >> |
|
| Tuesday, July 22, 2025 |
|
|
CMS Collaborates with SGX to Explore New Paradigms for Industrial Globalization and Pharmaceutical Expansion Overseas across Emerging Markets |
| On July 15 2025, to mark the successful secondary listing of China Medical System Holdings Limited ("CMS" or the "Group") on the Main Board of the Singapore Exchange ("SGX"), SGX and CMS co-hosted the "Singapore and Emerging Markets Pharmaceutical Industry Growth Forum & CMS SGX Secondary Listing Appreciation Dinner". more info >> |
|
| Monday, April 1, 2024 |
|
|
CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast Asia |
| more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
GA-ASI and Calidus Sign MOU To Collaborate on Co-Production of MQ-9B and Gambit Collaborative Combat Aircraft
Jan 21, 2026 05:00 HKT/SGT
|
|
|
The 2026 Polo Season Launches at the USPA National Polo Center, Sponsored by U.S. Polo Assn.
Jan 20, 2026 20:00 HKT/SGT
|
|
|
Asian Financial Forum opens next Monday with fresh perspective and new tagline, "Finance Empowering Business"
Jan 20, 2026 14:30 JST
|
|
|
Overview of Speeches Delivered at Launch Event for New Partnership between Honda and the Aston Martin Aramco Formula One(R) Team for 2026 Season
Jan 20, 2026 14:19 JST
|
|
|
"LEGENDARY HUMANITY", connecting humanity's treasures to the next generation, evolves into "VIVI PROJECT" 
Jan 20, 2026 12:30 HKT/SGT
|
|
|
Mitsubishi Motors Marks Record Sales in Vietnam for the Second Consecutive Year in 2025
Jan 20, 2026 12:35 JST
|
|
|
From Computing Chips to Physical AI: Nobel Laureate Hassabis' Trillion-Dollar Paradigm Forecast and 51WORLD's (6651.HK) Industry Breakthrough
Jan 20, 2026 10:59 HKT/SGT
|
|
|
Fujitsu recognized by World Economic Forum for project promoting sustainable hospital management leveraging AI
Jan 20, 2026 11:23 JST
|
|
|
GA-ASI and Barzan Holdings Sign MOU
Jan 20, 2026 07:00 HKT/SGT
|
|
|
DENSO to Promote Standardization of Automotive Software as an AUTOSAR Core Partner
Jan 19, 2026 16:00 JST
|
|
|
Asian Financial Forum opens next Monday as the region's first major international financial event of 2026
Jan 19, 2026 13:07 HKT/SGT
|
|
|
GA-ASI Makes Another Autonomous Aerial Intercept in Company-Funded Demo with MQ-20 Avenger(R)
Jan 19, 2026 10:00 HKT/SGT
|
|
|
Building the data infrastructure for next-generation materials science
Jan 19, 2026 08:00 HKT/SGT
|
|
|
New-look TGR-WRT launches landmark campaign on legendary rally
Jan 16, 2026 21:34 JST
|
|
|
Mitsubishi Corporation Announces Acquisition of Haynesville Shale Gas Business in Louisiana and Texas
Jan 16, 2026 21:12 JST
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
